CompanyAuto-indexed · Unverified
Cadrenal Therapeutics, Inc.
PONTE VEDRA, US SEC EDGAR
Every public capital-raising filing we've indexed for this company, over time. Compiled automatically from public sources — not verified by the company.
Filings
4
Total reported raised
$30.6M
People named
17
First indexed
2026
Funding history (4)
Jul 15, 2026Company raise· Biotechnology
Cadrenal Therapeutics, Inc. raised $8.8M
Raised
$8.8M
Apr 6, 2026Company raise· Biotechnology
Cadrenal Therapeutics, Inc. raised $7.9M
Raised
$7.9M
Dec 31, 2025Company raise· Biotechnology
Cadrenal Therapeutics, Inc. raised $4.4M
Raised
$4.4M
Nov 14, 2024Company raise· Biotechnology
Cadrenal Therapeutics, Inc. raised $9.4M
Raised
$9.4M
People named on filings
Douglas W. Losordo · Executive OfficerGLYNN WILSON · DirectorJames Ferguson · Executive OfficerJAMES J. FERGUSON · Executive OfficerJeff Cole · Executive OfficerJEFFREY COLE · Executive OfficerJeffrey S. Cole · Executive OfficerJohn P. Sharp · Executive OfficerJOHN R. MURPHY · DirectorLee Golden · DirectorLEE S. GOLDEN · DirectorMATTHEW K. SZOT · Executive OfficerMatthew Szot · Executive OfficerQuang Pham · DirectorQUANG X. PHAM · DirectorRobert Lisicki · DirectorSTEVEN ZELENKOFSKE · Director